The companies in the pace maker market are worth billions , The LVAD companies are worth billions and in between them two we have have us worth 60m but have a potentially larger market. Something has to give eventually on our market value being this low, you just want a decent piece at these levels before that happens. The worldwide market for heart failure is some 15-20m patients , there is a market for all these devices.
SHC Price at posting:
3.0¢ Sentiment: Buy Disclosure: Held
